Maust DT, Gerlach LB, Gibson A, Kales HC, Blow FC, Olfson M. Trends in central nervous system–active polypharmacy among older adults seen in outpatient care in the United States. JAMA Internal Medicine. 2017;177(4):583-585.
Maust DT, Kales HC, McCammon RJ, Blow FC, Leggett A, Langa KM. Distress associated with dementia-related psychosis and agitation in relation to healthcare utilization and costs. American Journal of Geriatric Psychiatry. 2017;25(10):1074-1082.
Maust DT, Kim HM, Chiang C, Kales HC. Association of the Centers for Medicare & Medicaid Services' National Partnership to Improve Dementia Care with use of antipsychotics and other psychotropics in long-term care in the United States from 2009–2014. JAMA Internal Medicine. 2018;178(5):640-647.
Maust DT, Lin LA, Blow FC. Benzodiazepine use and misuse among adults in the United States. Psychiatric Services. 2019;70(2):97-106.
Maust DT, Strominger J, Bynum JPW, Langa KM, Gerlach LB, Zivin K, Marcus SC. Prevalence of Psychotropic and Opioid Prescription Fills among Community-Dwelling Older Adults with Dementia in the U.S. JAMA. 2020 Aug;324:706-708.
Maust DT, Strominger S, Kim HM, Langa KM, Bynum JPW, Chang CH, Kales HC, Zivin K, Solway E, Marcus SC. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults with Dementia in the United States. JAMA. 2021;325(10):952-961.
Dr. Maust's publications on GoogleScholar
Dr. Maust's Bibliography on PubMed
